31 results on '"Doranz, Benjamin J."'
Search Results
2. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
3. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
4. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
5. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point
6. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
7. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
8. Testing for Off-target Binding
9. A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants.
10. Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
11. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
12. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
13. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
14. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
15. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
16. Abstract 2646: Screening the membrane proteome to determine antibody specificity and de-risk CAR-T cell development
17. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
18. Abstract 317: Isolation of highly selective antibodies against claudin 18.2 for the treatment of solid tumors
19. Abstract 318: Atomic-level specificity of Claudin 6 monoclonal antibodies isolated for treating solid tumors
20. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function
21. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
22. Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes
23. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
24. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection
25. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
26. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
27. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries.
28. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
29. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
30. The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics.
31. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.